CTDP-32476 HCl is an atypical dopamine (DA) transporter (DAT) inhibitor. CTDP-32476 HCl has potential as an agonist therapy for treatment of cocaine addiction. References: Point V, Bénarouche A, Zarrillo J, Guy A, Magnez R, Fonseca L, Raux B, Leclaire J, Buono G, Fotiadu F, Durand T, Carrière F, Vaysse C, Couedelo L, Cavalier JF. Slowing down fat digestion and absorption by an oxadiazolone inhibitor targeting selectively gastric lipolysis. Eur J Med Chem. 2016 Nov 10;123:834-48. doi: 10.1016/j.ejmech.2016.08.009. Epub 2016 Aug 8. PubMed PMID: 27543878.

纯度：≥98%

CAS：928046-68-8